Modules 1–5 were rich in cytokines (e.g., IL6, IL10), cytokine receptors (e.g., CCR2, CCR4), and immune cell markers (e.g., CD3D, CD3E), indicating that the DEGs primarily regulate the immune microenvironment rather than tumor malignancy traits like proliferation and invasion. This evidence concerns the gene CD3E and neoplasm.